Isofol Medical AB (publ) (FRA:5IU)

Germany flag Germany · Delayed Price · Currency is EUR
0.0448
-0.0010 (-2.18%)
At close: Mar 27, 2026
Market Cap16.99M -24.7%
Revenue (ttm)n/a
Net Income-5.01M
EPS-0.02
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0448
Previous Close0.0458
Day's Range0.0448 - 0.0448
52-Week Range0.0398 - 0.1764
Betan/a
RSI46.20
Earnings DateMay 19, 2026

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2008
Employees 6
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5IU

Financial Performance

Financial numbers in SEK Financial Statements